Study of a new Parkinson's injection and quality of life
Part of Brain & nervous system clinical trials.
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your Parkinson's disease must respond to levodopa medication.
- You must have advanced Parkinson's disease.
- Your doctor must have already decided to start you on the study drug (foslevodopa/foscarbidopa) before you were asked to join this study.
- You will be receiving the study drug as a continuous 24-hour injection under the skin, as approved.
- You cannot have any health condition that would make the study drug unsafe (as listed in the drug's label).
- You cannot be in another clinical trial for an experimental drug at the same time or within the last 30 days (other observational studies are fine).
- You must not have any ongoing skin issues (like eczema, psoriasis, or recent sunburn/tattoos/wounds) that could interfere with the injection site.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether measuring levodopa (a Parkinson medicine) in real time can help better understand Parkinson medication effects. You may be asked to wear/perform study monitoring while taking your usual carbidopa/levodopa tablets.
This study tests a new formulation of carbidopa-levodopa (IPX-203) to see how well it works for people with Parkinson's disease. It uses a wearable device to measure movement and aims to improve “off” time, when symptoms return between doses.
This study tests an injectable antibody called LY4006896, first in healthy volunteers and then in people with Parkinson's disease. It aims to see if the drug is safe and how it works in the body.
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
This study looks at how well a treatment called foslevodopa/foscarbidopa works for people with advanced Parkinson's disease. It is given as a shot under the skin (subcutaneous) and is already being used in clinics. The study will follow people who are already starting this treatment as part of their regular care.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.